Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
07. September 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9554
Articles 1 - 20 / 191074
Inflammasome-associated pyroptosis and tumor angiogenesis in prostate cancer.
Iran J Basic Med Sci
Al-Ameer HJ, Jameel RK, Nasretdinova M, Sultanov R, Polatova D, Alaal MA, Tailor NK, Singh R.
PMID: 42703256 [PubMed]
Predictive and prognostic biomarkers of Bacillus Calmette-Guérin therapy failure in bladder cancer patients: A systematic review.
Mol Oncol
Ribeiro-Pereira R, Teixeira-Marques A, Freitas R, Carvalho JA, Monteiro-Reis S, Russo GI, Henrique R, Jerónimo C.
PMID: 42703096 [PubMed - as supplied by publisher]
Multi-Omics Integration Identifies a Five-Gene Metabolic Signature With Experimental Validation in Clear Cell Renal Cell Carcinoma.
Cancer Rep (Hoboken)
Peng Y, Qin S, Li X, Wan L, Guan R.
PMID: 42702836 [PubMed - indexed for MEDLINE]
Segmental versus non-segmental inferior vena cava resection during robot-assisted radical nephrectomy and thrombectomy: an overlap-weighted analysis.
World J Urol
Guan Y, Yan Y, Xie R, Ge L, Tian X, Wang G, Ma L, Zhang H, Zhang S.
PMID: 42701915 [PubMed - indexed for MEDLINE]
Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming.
Mamm Genome
Mukherjee AG, Bharti AK, Mathew DM, Gopalakrishnan AV, Nishu S.
PMID: 42701157 [PubMed - indexed for MEDLINE]
Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.
Urol Oncol
Corvino R, Basile G, Santarelli V, Asero V, De Berardinis E, Sciarra A, Vittori L, Abu-Ghanem Y, Nair R, Khan MS, Thurairaja R, Barod R, Krajewski W, Laszkiewicz J, Albisinni S, Mori K, Guerrero-Ramos F, D'Andrea D, Gallioli A, Laukhtina E, Suleja A, Grobet-Jeandin E, Mari A, Mertens LS, Moschini M, De Angelis M, Scillipoti P, Soria F, Bosio A, Teoh J, Claps F, Amodeo A, , Contieri R, Subiela D, Tagalos A, Tully KH, Pichler R, Antonelli A, Bertolo R, Veccia A, Malandra S, Hurle R, Sormani F, Crocetto F, Mayr R, Porreca A, Simone G, Tuderti G, Rocco B, Simonato A, Simonato FA, Marcq G, Gontero P, Tian Z, Karakiewicz P, Chung BI, Pradere B, Del Giudice F.
PMID: 42701052 [PubMed - as supplied by publisher]
Long-term exposure to trihalomethanes in drinking water and risk of liver and kidney cancer: a population-based cohort study.
Environ Int
Helte E, Säve-Söderbergh M, Åkesson A.
PMID: 42700668 [PubMed - as supplied by publisher]
Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [(177)Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.
Biomed Pharmacother
Obeid K, Konijnenberg M, Bezverkhniaia E, Maina T, Nock BA, Tolmachev V, Kanellopoulos P, Orlova A.
PMID: 42700618 [PubMed - as supplied by publisher]
Integrative omics profiling of CRELD2 in ccRCC: a nexus of genetics, prognosis, and tumor microenvironment.
Inflamm Res
Liu S, Zhou Y, Fan L, Wang Y, Qu L, Zhou W.
PMID: 42700259 [PubMed - indexed for MEDLINE]
Risk of bone metastases on [(18)F]NaF PET/CT in 734 patients with newly diagnosed prostate cancer.
Eur J Nucl Med Mol Imaging
Madsen C, Zacho HD, Bisbjerg R, Fuglø D, Østergren PB.
PMID: 42700249 [PubMed - as supplied by publisher]
Feasibility of laparoscopic radical prostatectomy initiation by a surgeon with limited open surgery experience: A single-surgeon series with prior laparoscopic background.
Medicine (Baltimore)
Senoglu Y, Ediz E, Dilek IE, Ekici N, Baba D.
PMID: 42700081 [PubMed - indexed for MEDLINE]
Renal small cell neuroendocrine carcinoma: a case report and literature review.
Int J Surg Case Rep
Wei C, Wang X, Shayiremu D, Ren C.
PMID: 42699921 [PubMed]
Renal cell carcinoma in a child presenting with chronic gross hematuria: A rare case report with diagnostic and surgical insights.
Urol Case Rep
Harikatang AD, Siregar S, Majid GI.
PMID: 42699517 [PubMed]
Challenges in the initial diagnosis of colon carcinoma from symptoms of a bladder and colon fistula: a case report.
Int J Surg Case Rep
Duan JH, Wu YY, Wang WB, Zhang YP, Yang LP, Deng CH.
PMID: 42699440 [PubMed]
The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development.
Front Cell Dev Biol
Mann TJ, Becker TM, Roberts TL, de Souza P, Lock JG.
PMID: 42698629 [PubMed]
Cancer Expenditures and Mortality Trends in Brazil: An Ecological Population-Level Time-Series Analysis, 2008-2023.
Cancer Med
Fonseca LS, Pires LP, Alencar LMR, Ricci-Junior E, Santos-Oliveira R.
PMID: 42698132 [PubMed - indexed for MEDLINE]
Prostate surgery outcomes in patients presenting with and without a urethral catheter: a long-term comparative study.
World J Urol
Segal N, Ehrlich Y, Lifshitz D, Darawsha AE.
PMID: 42698027 [PubMed - indexed for MEDLINE]
[Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence].
Urologie
Gakis G, Vom Dorp F.
PMID: 42697960 [PubMed - as supplied by publisher]
Distinct Prognostic Roles of Grade Group and Intraductal Carcinoma of the Prostate in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Int J Urol
Ikeda J, Taniguchi H, Inoue M, Masuo Y, Nakamoto T, Taguchi M, Shimada S, Mishima T, Yanishi M, Uchida K, Kinoshita H.
PMID: 42697858 [PubMed - indexed for MEDLINE]
Reply to Francesco Di Bello, Andrea Gallioli, Joan Palou, and Alberto Breda's Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12.
Eur Urol Oncol
Contieri R, Hurle R.
PMID: 42697826 [PubMed - as supplied by publisher]
Articles 1 - 20 / 191074
Page 1 of 9554
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy